The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.

The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.

We studied 211 hyperandrogenic women with respect to clinical presentation, basal androgen levels, and the degree of cortisol and androgen suppression during a 48-h low-dose (2 mg) dexamethasone-suppression test (LDDST) to exclude ovarian and adrenal tumors. In 42 women with elevated testosterone le...

Descrición completa

Detalles Bibliográficos
Main Authors:	Kaltsas, G, Isidori, A, Kola, B, Skelly, R, Chew, S, Jenkins, P, Monson, J, Grossman, AB, Besser, G
Formato:	Journal article
Idioma:	English
Publicado:	2003

Títulos similares

Authors' response: The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women
por: Kaltsas, G, et al.
Publicado: (2003)

Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
por: Isidori, A, et al.
Publicado: (2003)

Discriminatory value of low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome - Response
por: Isidori, A, et al.
Publicado: (2004)

Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
por: Kaltsas, G, et al.
Publicado: (2003)

Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply
por: Monson, J, et al.
Publicado: (2001)

CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
por: Grossman, AB, et al.
Publicado: (1988)

The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome.
por: Dias, R, et al.
Publicado: (2006)

Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil.
por: Kaltsas, G, et al.
Publicado: (2002)

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
por: Florakis, D, et al.
Publicado: (2000)

The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.
por: Isidori, A, et al.
Publicado: (2006)

Secondary forms of polycystic ovary syndrome.
por: Kaltsas, G, et al.
Publicado: (2004)

The prevalence and characteristic features of cyclicity and variability in Cushing's disease.
por: Alexandraki, K, et al.
Publicado: (2009)

Ocular metastases secondary to carcinoid tumors: the utility of imaging with [(123)I]meta-iodobenzylguanidine and [(111)In]DTPA pentetreotide.
por: Isidori, A, et al.
Publicado: (2002)

Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
por: Kaltsas, G, et al.
Publicado: (2001)

Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis.
por: Storr, H, et al.
Publicado: (2004)

How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
por: Kaltsas, G, et al.
Publicado: (2000)

Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
por: Kaltsas, G, et al.
Publicado: (2001)

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
por: Jenkins, P, et al.
Publicado: (2000)

Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas.
por: Woo, Y, et al.
Publicado: (2005)

The diagnosis and medical management of advanced neuroendocrine tumors.
por: Kaltsas, G, et al.
Publicado: (2004)

DIAGNOSIS OF HYPERANDROGENISM: DIFFICULTY AND THE CONSEQUENCES
por: N. I. Volkova, et al.
Publicado: (2017-03-01)

Uterine leiomyomata in women with acromegaly
por: Kaltsas, G, et al.
Publicado: (2000)

GnRH analogue use in postmenopausal hyperandrogenism: long-term remission.
por: Gueorguiev, M, et al.
Publicado: (2012)

GnRH analogue use in postmenopausal hyperandrogenism: long-term remission
por: Gueorguiev, M, et al.
Publicado: (2011)

The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors.
por: Kaltsas, G, et al.
Publicado: (1998)

Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome.
por: Rockall, A, et al.
Publicado: (2003)

Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography.
por: Rockall, A, et al.
Publicado: (2003)

THE CRF TEST IN THE DIAGNOSIS OF ACTH-DEPENDENT CUSHINGS-SYNDROME - A COMPARISON WITH DEXAMETHASONE
por: Grossman, A, et al.
Publicado: (1987)

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
por: Drake, WM, et al.
Publicado: (1998)

Alterations in serum protein levels in patients with Cushing's syndrome before and after successful treatment.
por: Putignano, P, et al.
Publicado: (2000)

Ectopic ACTH syndrome.
por: Isidori, A, et al.
Publicado: (2006)

The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
por: Kaltsas, G, et al.
Publicado: (2001)

Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment.
por: Kaltsas, G, et al.
Publicado: (2000)

Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
por: Newell-Price, J, et al.
Publicado: (2002)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
por: Korbonits, M, et al.
Publicado: (1999)

An Optimized Pathway for the Differential Diagnosis of ACTH-Dependent Cushing’s Syndrome Based on Low-Dose Dexamethasone Suppression Test
por: Kang Chen, et al.
Publicado: (2021-09-01)

Menstrual irregularity in women with acromegaly.
por: Kaltsas, G, et al.
Publicado: (1999)

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
por: Mukherjee, J, et al.
Publicado: (2001)

Hyperandrogenic eumenorrheic NON-PCOS women versus women with PCOS after the GnRH-agonist stimulation test preceded by suppression of adrenal steroidogenesis with dexamethasone
por: Salvatore Benvenga, et al.
Publicado: (2024-09-01)

Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study.
por: Alexandraki, K, et al.
Publicado: (2013)